Cystoscope Market Size, Share, Opportunities, And Trends By Type (Rigid Cystoscope, Flexible Cystoscope), By Applications (Urology, Gynaecology), By End-User (Hospitals, Ambulatory Surgical Centres), And By Geography - Forecasts From 2025 To 2030

  • Published : May 2025
  • Report Code : KSI061611601
  • Pages : 145
excel pdf power-point

Cystoscope Market Size:

The Cystoscope Market is expected to grow from US$294.223 million in 2025 to US$375.455 million in 2030, at a CAGR of 5.00%.

A cystoscope is a thin, telescope-like tube with a light and tiny camera attached instrument used to perform a cystoscopy, also known as cystourethroscopy that allows a physician to examine and treat the lower urinary tract (urethra, prostate, bladder neck, and bladder). The cystoscope is inserted into the bladder through the urethra for the evaluation, treatment, or diagnosis of the conditions such as Bladder cancer, haematuria, frequent urinary tract infections (UTIs), Urinary blockage, Urinary stones, etc. making cystoscopy procedures one of the most commonly performed procedures in the urology office settings. Major companies have been providing novel and advanced solutions for their customers. For instance, Ambu, one of the largest suppliers of innovative and advanced single-use endoscopes, would be providing solutions for urology, in the coming years. The company had announced that it would launch a novel single-use, sterile, and high-resolution cystoscope in the year 2022. The company had also stated that they would launch a novel and single-use digital flexible ureteroscope in the year 2022. These trends and developments are expected to play a major role in the market growth, during the forecast period.

Cystoscope Market Growth Driver:

  • Rising incidences of urinary tract diseases boost the market.

The growth in the global cystoscope market may be attributed to the rising prevalence of urinary tract diseases globally. As per the data from the National Kidney Foundation, there are approximately 10 million doctor visits for urinary tract infections in the US. Similar rising incidences of other diseases such as prostate cancer, stones, bladder cancer, etc. will also boost the market during the given time frame. As per Cancer Research UK, prostate cancer is the most common cancer in men with around 47,700 new prostate cancer cases in the UK every year. However, complications such as infections, bleeding, and swollen urethra that may arise during cystoscopy procedures might restrain the growth of the market during the forecast period. According to a journal published in the United States National Library of Medicine National Institutes of Health, urinary tract infections are one of the most common infections, with an average lifetime incidence of 50-60% in most adult women. Urinary tract infections are some of the most common infections in the United States. The prevalence in women over 65 years is around 20%, compared with around 11% of the overall population. Moreover, there are around 258,000 cases of pyelonephritis in the United States, per year, with a higher and bigger frequency among females. In women, who are aged between 18-49 years, the total approximate incidence of pyelonephritis is around 28/10,000. These trends are expected to accelerate the demand for novel cystoscope devices and applications, in the coming years.

Cystoscope Market Geographical Outlook:

  • The Asia Pacific has a major share.

The market is expected to surge in the region due to the rising cases of urinary infections and prostate cancer. In India, according to the Indian Council of Medical Research, the incidence rate of prostate cancer in the country had been around 9-10/per 100,000 population, which is comparatively higher as compared to countries in Asia and Africa. In China, according to the National Cancer Registration Institute, prostate cancer has been the most common tumor in the male urinary system since the year 2008. These trends are expected to accelerate the demand for novel and advanced cystoscope products and systems.

Cystoscope Market Scope:

Report Metric Details
Cystoscope Market Size in 2025 US$294.223 million
Cystoscope Market Size in 2030 US$375.455 million
Growth Rate CAGR of 5.00%
Study Period 2020 to 2030
Historical Data 2020 to 2023
Base Year 2024
Forecast Period 2025 – 2030
Forecast Unit (Value) USD Million
Segmentation
  • Type
  • Applications
  • End-User
  • Geography
Geographical Segmentation North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in Cystoscope Market
  • Stryker
  • PENTAX Medical
  • Olympus Medical Corporation
  • Richard Wolf GmbH
  • Karl Storz
Customization Scope Free report customization with purchase

 

The cystoscope market is analyzed into the following segments:

  • By Type
    • Rigid Cystoscope
    • Flexible Cystoscope
  • By Applications
    • Urology
    • Gynecology
  • By End-User
    • Hospitals
    • Ambulatory Surgical Centers
  • By Geography
    • North America
      • USA
      • Canadá
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Others
    • Middle East and Africa
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Thailand
      • Taiwan
      • Indonesia
      • Others

Frequently Asked Questions (FAQs)

The cystoscope market is expected to reach a total market size of US$375.455 million by 2030.

Cystoscope Market is valued at US$294.223 million in 2025.

The cystoscope market is expected to grow at a CAGR of 5.00% during the forecast period.

The Asia Pacific region is anticipated to hold a significant share of the cystoscope market.

Prominent key market players in the cystoscope market include Karl Storz, NeoScope Inc., Coloplast Group, Cogentix Medical, Henke-Sass Wolf, Advanced Health Care Resources, among others.

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. CYSTOSCOPE MARKET BY TYPE

5.1. Introduction

5.2. Rigid Cystoscope

5.3. Flexible Cystoscope

6. CYSTOSCOPE MARKET BY REUSABILITY

6.1. Introduction

6.2. By Reusability

6.3. Reusable Cystoscopes

6.4. Disposable Cystoscopes

7. CYSTOSCOPE MARKET BY TECHNOLOGY

7.1. Introduction

7.2. Standard Imaging

7.3. High-Definition (HD) Imaging

7.4. Narrow-Band Imaging

8. CYSTOSCOPE MARKET BY APPLICATION

8.1. Introduction

8.2. Urology

8.3. Gynaecology

8.4. Oncology

8.5. Research

9. CYSTOSCOPE MARKET BY END-USER

9.1. Introduction

9.2. Hospitals

9.3. Ambulatory Surgical Centers

9.4. Urology Clinics

9.5. Diagnostic Centers

10. CYSTOSCOPE MARKET BY GEOGRAPHY

10.1. Introduction

10.2. North America

10.2.1. By Type

10.2.2. By Reusability

10.2.3. By Technology

10.2.4. By Application

10.2.5. By End-User

10.2.6. By Country

10.2.6.1. USA

10.2.6.2. Canada

10.2.6.3. Mexico

10.3. South America

10.3.1. By Type

10.3.2. By Reusability

10.3.3. By Technology

10.3.4. By Application

10.3.5. By End-User

10.3.6. By Country

10.3.6.1. Brazil

10.3.6.2. Argentina

10.3.6.3. Others

10.4. Europe

10.4.1. By Type

10.4.2. By Reusability

10.4.3. By Technology

10.4.4. By Application

10.4.5. By End-User

10.4.6. By Country

10.4.6.1. United Kingdom

10.4.6.2. Germany

10.4.6.3. France

10.4.6.4. Spain

10.4.6.5. Others

10.5. Middle East and Africa

10.5.1. By Type

10.5.2. By Reusability

10.5.3. By Technology

10.5.4. By Application

10.5.5. By End-User

10.5.6. By Country

10.5.6.1. Saudi Arabia

10.5.6.2. UAE

10.5.6.3. Others

10.6. Asia Pacific

10.6.1. By Type

10.6.2. By Reusability

10.6.3. By Technology

10.6.4. By Application

10.6.5. By End-User

10.6.6. By Country

10.6.6.1. China

10.6.6.2. Japan

10.6.6.3. India

10.6.6.4. South Korea

10.6.6.5. Taiwan

10.6.6.6. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

11.1. Major Players and Strategy Analysis

11.2. Market Share Analysis

11.3. Mergers, Acquisitions, Agreements, and Collaborations

11.4. Competitive Dashboard

12. COMPANY PROFILES

12.1. Stryker Corporation

12.2. PENTAX Medical

12.3. Olympus Medical Corporation

12.4. Richard Wolf GmbH

12.5. Karl Storz SE & Co. KG

12.6. NeoScope Inc.

12.7. Coloplast Group

12.8. Cogentix Medical Inc. (Laborie)

12.9. Henke-Sass Wolf

12.10. Ambu A/S

12.11. Boston Scientific Corporation

12.12. Laborie Medical Technologies, Inc.

13. APPENDIX

13.1. Currency 

13.2. Assumptions

13.3. Base and Forecast Years Timeline

13.4. Key Benefits for the Stakeholders

13.5. Research Methodology 

13.6. Abbreviations

Stryker Corporation

PENTAX Medical

Olympus Medical Corporation

Richard Wolf GmbH

Karl Storz SE & Co. KG

NeoScope Inc.

Coloplast Group

Cogentix Medical Inc. (Laborie)

Henke-Sass Wolf

Ambu A/S

Boston Scientific Corporation

Laborie Medical Technologies, Inc.